Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP.
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
View in:
PubMed
subject areas
Administration, Ophthalmic
Angiogenesis Inhibitors
Bevacizumab
Child, Preschool
Fluorescein Angiography
Humans
Infant
Laser Coagulation
Refraction, Ocular
Retinopathy of Prematurity
Retrospective Studies
Time Factors
authors with profiles
Michael P Blair
Mark Greenwald
Sarah Rodriguez